8-K – Page 377 – China Stock Advice

ALN [American Lorain] 8-K: FORM 8-K CURRENT REPORT Date of report (Date

[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported) (May 16, 2014) AMERICAN LORAIN CORPORATION Nevada 001-34449 87-0430320 (State or other jurisdiction of (I.R.S. employer incorporation) identification no.) Shandong, China 276600 Beihuan Road Junan County (86) 539-7317959 Item 5.02 Departure of Directors and Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.]

By info| 2016-04-03T03:46:24+00:00 May 20th, 2014|Categories: ALN, Chinese Stocks, Webplus ver|Tags: 0001117057, 2014-05-20, 2030, 8-K, ALN, CANNED, FROZEN and PRESERVED FRUIT, VEG and FOOD SPECIALTIES|0 Comments

KGJI [KINGOLD JEWELRY] 8-K: (Original Filing)

[KINGOLD JEWELRY REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2014 Company to Hold Conference Call on Thursday, May 15, 2014, at 5:30 PM ET Company Reiterates 2014 Guidance of Between 60 metric tons and 70 metric tons of Gold Processed During 2014 WUHAN CITY, China, May 15, 2014 - Kingold Jewelry, Inc. ("Kingold" or "the Company") (NASDAQ:] []

By info| 2016-04-11T01:28:13+00:00 May 19th, 2014|Categories: Chinese Stocks, KGJI, SEC Original|Tags: 0001089531, 2014-05-19, 7389, 8-K, KGJI, SERVICES-BUSINESS SERVICES, NEC|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Third Quarter Fiscal Year 2014 Financial Results Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the third quarter fiscal year 2014. Third Quarter Fiscal 2014 Ended March 31, 2014 Financial Highlights: · Revenue was $8.6] [Tianyin Pharmaceutical Inc. Third Quarter Fiscal Year 2014 Financial Results Conference Call May 15, 2014 Operator I will now turn the conference over to Dr. James Tong, Chief Financial Officer. Please go ahead. James Jiayuan Tong - Chief Financial Officer: Third quarter of fiscal year 2014 ended March 31, 2014 financial highlights. · Revenue was $8.6 million versus $15.5 million] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 15, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28- 8551-6696 o o]

By info| 2016-03-19T15:33:24+00:00 May 19th, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 2014-05-19, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Third Quarter Fiscal Year 2014 Financial

[TPI Reports Third Quarter Fiscal Year 2014 Financial Results Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the third quarter fiscal year 2014. Third Quarter Fiscal 2014 Ended March 31, 2014 Financial Highlights: · Revenue was $8.6] [Tianyin Pharmaceutical Inc. Third Quarter Fiscal Year 2014 Financial Results Conference Call May 15, 2014 Operator I will now turn the conference over to Dr. James Tong, Chief Financial Officer. Please go ahead. James Jiayuan Tong - Chief Financial Officer: Third quarter of fiscal year 2014 ended March 31, 2014 financial highlights. · Revenue was $8.6 million versus $15.5 million] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 15, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28- 8551-6696 o o]

By info| 2016-03-19T15:34:25+00:00 May 19th, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 2014-05-19, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

SORL [SORL Auto Parts] 8-K: (Original Filing)

[SORL Auto Parts Reports Net Income - Revenues Increased by 21.1% with Gross Margin Rising to 30.8% ZHEJIANG, China, May 16, 2014 -- SORL Auto Parts, Inc. (NASDAQ: SORL) First Quarter Financial Highlights · Revenues for the first quarter of 2014 increased by 21.1% to $50.0 million; · Gross margin increased to 30.8% in the first quarter of 2014; ·] []

By info| 2016-03-18T21:42:53+00:00 May 16th, 2014|Categories: Chinese Stocks, SEC Original, SORL|Tags: 0000714284, 2014-05-16, 3714, 8-K, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

SORL [SORL Auto Parts] 8-K: SORL Auto Parts Reports Net Income – Revenues

[SORL Auto Parts Reports Net Income - Revenues Increased by 21.1% with Gross Margin Rising to 30.8% ZHEJIANG, China, May 16, 2014 -- SORL Auto Parts, Inc. (NASDAQ: SORL) First Quarter Financial Highlights · Revenues for the first quarter of 2014 increased by 21.1% to $50.0 million; · Gross margin increased to 30.8% in the first quarter of 2014; ·] []

By info| 2016-03-18T21:44:44+00:00 May 16th, 2014|Categories: Chinese Stocks, SORL, Webplus ver|Tags: 0000714284, 2014-05-16, 3714, 8-K, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

CLNT [Cleantech Solutions International] 8-K: (Original Filing)

[Cleantech Solutions International Reports First Quarter 2014 Results · First quarter 2014 revenues rose 27% to $17.6 million · Net income increased 48% to $2.4 million, or $0.68 per basic and diluted share Wuxi, Jiangsu Province, China May 15, 2014 “We began the year on solid footing, generating profitable growth and strong operating cash flow. Our dyeing machine segment continues] [Cleantech Solutions International Announces Conference Call to Discuss First Quarter 2014 Financial Results WUXI, Jiangsu, China, May 13, 2014 - Cleantech Solutions International, Inc. ("Cleantech Solutions" or "the Company") (CLNT), a manufacturer of metal components and assemblies used in various clean technology and manufacturing industries and textile dyeing and finishing machines, today announced that it will conduct a conference call] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): May 14, 2014 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Nevada 001-34591 90-0648920 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China (86) 51083397559 Copies to: Asher S.]

By info| 2016-03-26T12:23:05+00:00 May 16th, 2014|Categories: Chinese Stocks, CLNT, SEC Original|Tags: 0000819926, 2014-05-16, 3550, 8-K, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

CLNT [Cleantech Solutions International] 8-K: Cleantech Solutions International Reports First Quarter 2014 Results

[Cleantech Solutions International Reports First Quarter 2014 Results · First quarter 2014 revenues rose 27% to $17.6 million · Net income increased 48% to $2.4 million, or $0.68 per basic and diluted share Wuxi, Jiangsu Province, China May 15, 2014 “We began the year on solid footing, generating profitable growth and strong operating cash flow. Our dyeing machine segment continues] [Cleantech Solutions International Announces Conference Call to Discuss First Quarter 2014 Financial Results WUXI, Jiangsu, China, May 13, 2014 - Cleantech Solutions International, Inc. ("Cleantech Solutions" or "the Company") (CLNT), a manufacturer of metal components and assemblies used in various clean technology and manufacturing industries and textile dyeing and finishing machines, today announced that it will conduct a conference call] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): May 14, 2014 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Nevada 001-34591 90-0648920 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China (86) 51083397559 Copies to: Asher S.]

By info| 2016-03-26T12:25:27+00:00 May 16th, 2014|Categories: Chinese Stocks, CLNT, Webplus ver|Tags: 0000819926, 2014-05-16, 3550, 8-K, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[Amended and Restated Employment Agreement Agreement Company Executive This Amended and Restated Employment Agreement (this “ Original Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ WHEREAS, the term of the Original Agreement will expire on May 11, 2014; and WHEREAS, the Company and the Executive desire to extend] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 11, 2014 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3166 ____________________________________________________________ (Former name or former]

By info| 2016-03-25T06:21:33+00:00 May 15th, 2014|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2014-05-15, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 8-K: Amended and Restated Employment Agreement Agreement Company Executive

[Amended and Restated Employment Agreement Agreement Company Executive This Amended and Restated Employment Agreement (this “ Original Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ WHEREAS, the term of the Original Agreement will expire on May 11, 2014; and WHEREAS, the Company and the Executive desire to extend] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 11, 2014 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3166 ____________________________________________________________ (Former name or former]

By info| 2016-03-25T06:22:24+00:00 May 15th, 2014|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2014-05-15, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments